Spotlight
Video

BOLERO-3 Trial Commentary

Loading........
Description: For more updates visit www.oncologyeducation.com....

Dr. Sunil Verma commenting on ASCO 2013 abstract #505: Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer
Shared By : oncologyeducation
Posted on : 06/23/13
Added : 4 years ago
Category : Breast Cancer



More From oncologyeducation

Nothing found.